NHS Trial: Lupus Patients Achieve Remission with Gene-Modified Cell Therapy
Doctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune disease Five lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies their own cells, in a medical breakthrough that could offer people a cure, doctors have said. CAR (chimeric antigen receptor) T-cell therapy involves removing a type of white blood cell also called T lymphocytes, which are crucial for hunting out
Five individuals in England suffering from lupus have entered remission following a groundbreaking trial utilizing genetically modified T-cell therapy. This innovative treatment, known as CAR T-cell therapy, involves extracting a patient's T-lymphocytes, re-engineering them to target and eliminate disease-causing elements, and then reintroducing them to reset the immune system. Doctors involved in the National Health Service (NHS) trial are optimistic that this approach could represent a significant step towards a cure for the chronic autoimmune condition.
This pioneering therapy offers a potential cure for lupus, a chronic autoimmune disease, by resetting the patient's immune system.
📌 Kaynak
Bu özet Guardian World kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →